* If you are interested in this study please be sure to fill out the form at the bottom of this page
Osteoarthritis or OA is the most common form of arthritis and is a typical cause of joint pain and disability. OA occurs when the cartilage in the joint breaks down, causing pain, inflammation and problems moving the joint. The age of onset and progression can vary from person to person, however, most patient's symptoms begin with joint pain and functional limitations.
Osteoarthritis most often occurs in the knees, hips, lower back and joints in the hands. As the cartilage wears away and the OA progresses, the bones may begin to rub directly against one another, causing the bones to break down and develop osteophytes. Osteophytes, or more commonly known as "bone spurs", are bony projections that develop in the joint. There are various factors that may contribute to the development of osteoarthritis including, genetic causes, being overweight and injury or overuse. X-ray and MRI are the most common diagnostic tools for assessing osteoarthritis, as the changes to the joint can be seen and evaluated.
At Bluewater Clinical Research Group, we are proud to contribute to the research that may one day lead to the development of novel treatments for osteoarthritis. We are currently enrolling patients with a diagnosis of OA of the knee for an exciting clinical trial.
To find out more, or see if you may qualify, please provide us with your contact information and one of our enrolment facilitators will be happy to get in touch with you. As everyone has different schedules, we may even text you to set up a good time to talk.
To see if you qualify, please provide us with your contact information below. As everyone has different schedules, we may even text you to set up a time to connect. Thank you.
We would love to hear from you! Want to learn more about clinical studies in general or wish to explore whether you would qualify for a specific clinical trial? Connect with us today!
COPD is a progressive lung disease characterized by persistent airflow limitation or obstruction and an inflammatory response of the airways and lungs